Blocking inflammasome-induced neuroinflammation in PD with a potent, orally available small molecule (2016–2020)

Grant type:
The Michael J Fox Foundation Therapeutic Pipeline Program
Researchers:
Funded by:
The Michael J Fox Foundation for Parkinsons Research